Viewing Study NCT06352008


Ignite Creation Date: 2025-12-26 @ 10:58 AM
Ignite Modification Date: 2025-12-26 @ 10:58 AM
Study NCT ID: NCT06352008
Status: RECRUITING
Last Update Posted: 2025-11-20
First Post: 2024-04-02
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: To Evaluate the Efficacy and Safety of Anlotinib Hydrochloride Capsule in Postoperative Non-pCR Patients With Non-small Cell Lung Cancer
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-07-01
Start Date Type: ACTUAL
Primary Completion Date: 2026-06-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2027-06-01
Completion Date Type: ESTIMATED
First Submit Date: 2024-04-02
First Submit QC Date: None
Study First Post Date: 2024-04-08
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-11-17
Last Update Post Date: 2025-11-20
Last Update Post Date Type: ESTIMATED